Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection

被引:14
作者
Liao, Rui [1 ]
Wei, Xu-Fu [1 ]
Che, Ping [2 ,3 ]
Yin, Kun-Li [1 ]
Liu, Lei [1 ]
机构
[1] Chongqing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Chongqing, Peoples R China
[2] Chongqing Med Univ, Dept Urol, Affiliated Hosp 1, Chongqing, Peoples R China
[3] Matern & Child Hlth Hosp Chongqing Hechuan, Dept Pediat Surg, Chongqing, Peoples R China
关键词
hepatocellular carcinoma; China liver cancer staging system; nomogram; surgery; recurrence; prognosis; LIVER-CANCER; ALPHA-FETOPROTEIN; METASTASIS; RECURRENCE; GUIDELINES; DIAGNOSIS; CELLS;
D O I
10.3389/fonc.2021.755920
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposePrediction models of postoperative outcomes of patients with hepatocellular carcinoma (HCC) after surgery based on the China liver cancer (CNLC) staging system are rare. This study aimed to compare the prognostic abilities of CNLC, Tumor-Node-Metastasis (TNM) 8th edition, and Barcelona Clinic Liver Cancer (BCLC) staging systems for HCC after curative resection. We developed two nomograms incorporating the CNLC staging system to predict the postoperative recurrence-free survival (RFS) and overall survival (OS) of HCC patients. Patients and methodsThe prognostic abilities of the CNLC, TNM and BCLC staging systems for HCC after curative resection were compared using receiver operating characteristic (ROC) curves. Two nomograms incorporating five selected risk factors were constructed based on multivariate Cox regression in the primary cohort of 312 HCC patients. It was validated with an independent validation cohort of 130 HCC patients. The predictive performance and discrimination ability of the two nomograms were further evaluated and compared with those of the TNM and BCLC staging systems. ResultsThe CNLC staging system had a higher area under the receiver operating characteristic curve (AUROC) value for both OS (AUC=0.692) and RFS (AUC=0.673) than the TNM (ROC=0.667 for OS and 0.652 for RFS) and BCLC (ROC=0.671 for OS and 0.670 for RFS) staging systems. The independent predictors of OS (cirrhosis, gamma-glutamyl transpeptidase (GGT), tumor differentiation and CNLC staging system) and RFS (alpha-fetoprotein (AFP) and CNLC staging system) were incorporated into the two nomograms. The OS and RFS nomograms consistently outperformed the TNM and BCLC staging systems in the primary cohort. These results were verified in the validation cohort. In the 442 patients with HCC, the RFS nomogram could predict early recurrence very well. ConclusionThe two proposed nomograms incorporating the CNLC staging system can predict the outcomes of patients with HCC after curative hepatectomy in clinical practice.
引用
收藏
页数:10
相关论文
共 38 条
[1]   Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma [J].
Adachi, Makiko ;
Kai, Keita ;
Yamaji, Koutaro ;
Ide, Takao ;
Noshiro, Hirokazu ;
Kawaguchi, Atsushi ;
Aishima, Shinichi .
HISTOPATHOLOGY, 2019, 75 (01) :63-73
[2]   Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems [J].
Bednarsch, Jan ;
Czigany, Zoltan ;
Heise, Daniel ;
Joechle, Katharina ;
Luedde, Tom ;
Heij, Lara ;
Bruners, Philipp ;
Ulmer, Tom Florian ;
Neumann, Ulf Peter ;
Lang, Sven Arke .
LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (01) :75-86
[3]   Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma [J].
Bruix, Jordi ;
Reig, Maria ;
Sherman, Morris .
GASTROENTEROLOGY, 2016, 150 (04) :835-853
[4]   Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature [J].
Campigotto, Michele ;
Giuffre, Mauro ;
Colombo, Anna ;
Visintin, Alessia ;
Aversano, Alessandro ;
Budel, Martina ;
Masutti, Flora ;
Abazia, Cristiana ;
Croce, Lory Saveria .
WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (12) :1239-1257
[5]   Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China [J].
Chen, Zhen-Hua ;
Zhang, Xiu-Ping ;
Feng, Jin-Kai ;
Li, Le-Qun ;
Zhang, Fan ;
Hu, Yi-Ren ;
Zhong, Cheng-Qian ;
Shi, Jie ;
Guo, Wei-Xing ;
Wu, Meng-Chao ;
Lau, Wan Yee ;
Cheng, Shu-Qun .
HEPATOLOGY INTERNATIONAL, 2021, 15 (03) :642-650
[6]   Prospective validation of the Barcelona Clinic Liver Cancer staging system [J].
Cillo, U ;
Vitale, A ;
Grigoletto, F ;
Farinati, F ;
Brolese, A ;
Zanus, G ;
Neri, D ;
Boccagni, P ;
Srsen, N ;
D'Amico, F ;
Ciarleglio, FA ;
Bridda, A ;
D'Amico, DF .
JOURNAL OF HEPATOLOGY, 2006, 44 (04) :723-731
[7]  
Corti A, 2010, ANTICANCER RES, V30, P1169
[8]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[9]   Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1 [J].
Jin, Haojie ;
Wang, Cun ;
Jin, Guangzhi ;
Ruan, Haoyu ;
Gu, Dishui ;
Wei, Lin ;
Wang, Hui ;
Wang, Ning ;
Arunachalam, Einthavy ;
Zhang, Yurong ;
Deng, Xuan ;
Yang, Chen ;
Xiong, Yi ;
Feng, Hugang ;
Yao, Ming ;
Fang, Jingyuan ;
Gu, Jianren ;
Cong, Wenming ;
Qin, Wenxin .
GASTROENTEROLOGY, 2017, 153 (03) :799-+
[10]   Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade [J].
Johnson, Philip J. ;
Berhane, Sarah ;
Kagebayashi, Chiaki ;
Satomura, Shinji ;
Teng, Mabel ;
Reeves, Helen L. ;
O'Beirne, James ;
Fox, Richard ;
Skowronska, Anna ;
Palmer, Daniel ;
Yeo, Winnie ;
Mo, Frankie ;
Lai, Paul ;
Inarrairaegui, Mercedes ;
Chan, Stephen L. ;
Sangro, Bruno ;
Miksad, Rebecca ;
Tada, Toshifumi ;
Kumada, Takashi ;
Toyoda, Hidenori .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :550-U45